English
Syncom Formulations India Ltd Q1 Results
- BSE: 524470
- NSE: SYNCOMF
- ISIN: INE312C01025
- Sector: Biotechnology & Drugs
BSE
12.16
-0.05 (-0.41%)
-0.05 (-0.41%)Volume67.44 K
Updated: Fri 23 Jan, 2026 | 11:26:56
NSE
12.14-0.10 (-0.82%)
-0.10 (-0.82%)Volume4.82 L
Updated: Fri 23 Jan, 2026 | 11:11:58
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q1 Results Highlights
Quarter ended Jun 25
Note: Comparison is on QoQ basis
Quarterly - Syncom Formulations India Ltd Q1 Results
*All figures in crores except per share values
| Fiscal Period | Jun 25 | Mar 25 | QoQ Comp | Jun 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 102.39 | 132.41 | -22.67% | 78.10 | 31.10% |
| Depreciation/ Amortization | 1.34 | 1.29 | 4.17% | 1.30 | 3.08% |
| Operating Income | 14.51 | 16.47 | -11.92% | 9.15 | 58.49% |
| Net Income | 15.75 | 17.69 | -10.96% | 7.63 | 106.41% |
| Other Operating Expenses Total | 15.97 | 15.78 | 1.18% | 12.64 | 26.36% |
| Net Income Before Taxes | 20.29 | 23.30 | -12.91% | 10.10 | 100.87% |
| Total Revenue | 116.90 | 148.88 | -21.48% | 87.26 | 33.98% |
| Selling/ General/ Admin Expenses Total | 15.95 | 14.97 | 6.54% | 9.65 | 65.34% |
| Diluted Normalized EPS | 0.21 | 0.16 | 31.03% | 0.11 | 90.52% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.